Table 6.
Characteristic | Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|
HR | P Value | HR | P Value | 95% CI | |
Age | |||||
< 50 y | Referent | Referent | |||
≥50 y | 0.4 | <0.0001 | 0.6 | 0.01 | 0.4–0.9 |
IM drainage | 0.9 | 0.5 | |||
UOQ tumor location | 1.0 | 0.997 | |||
Medial tumor location | 1.1 | 0.7 | |||
LVI | 1.5 | 0.03 | 1.6 | 0.03 | 1.04–2.3 |
Nuclear grade | |||||
1 | Referent | ||||
2 | 0.9 | 0.6 | 0.8 | 0.5 | 0.5–1.4 |
3 | 1.7 | 0.04 | 1.2 | 0.5 | 0.7–2.2 |
Tumor stage | |||||
T1 | Referent | Referent | |||
T2 | 1.6 | 0.007 | 1.5 | 0.03 | 1.04–2.1 |
T3 | 2.3 | 0.046 | 2.2 | 0.07 | 0.9–5.4 |
Negative ER status | 2.4 | <0.0001 | 2.8 | <0.0001 | 2.0–3.9 |
Negative PR status | 1.3 | 0.06 | 0.8 | 0.2 | 0.5–1.1 |
Negative HER-2 status | 0.9 | 0.5 | |||
Tumor histology | |||||
IDC | Referent | ||||
ILC | 0.9 | 0.6 | |||
IDC and ILC | 0.8 | 0.5 | |||
Other | 1.3 | 0.4 | |||
Number of positive LNsa | 1.1 | 0.003 | 1.3 | 0.03 | 1.02–1.7 |
HR indicates hazards ratio; CI, confidence interval; IM, internal mammary; UOQ, upper outer quadrant; LVI, lymphovascular invasion; ER, estrogen receptor; PR, progesterone receptor; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LN, lymph node.
As a continuous variable.